Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Thu, February 16, 2012
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
Tue, February 14, 2012
Mon, February 13, 2012
Sun, February 12, 2012
Fri, February 10, 2012
Thu, February 9, 2012
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ] - Market Wire
Imaging3 Updates Website
Tue, February 7, 2012

Amgen to Present at the Leerink Swann Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. -leerink-swann-global-healthcare-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Amgen to Present at the Leerink Swann Global Healthcare Conference -- THOUSAND OAKS, Calif., Feb. 13, 2012 /PRNewswire/ --

Amgen to Present at the Leerink Swann Global Healthcare Conference

[ ]

THOUSAND OAKS, Calif., Feb. 13, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) will present at the Leerink Swann Global Healthcare Conference at 9:30 a.m. Eastern Standard Time on Thursday, Feb. 16, 2012, at the Waldorf Astoria Hotel in New York City.  Jonathan M. Peacock, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, [ www.amgen.com ], under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit [ www.amgen.com ].  Follow us on [ www.twitter.com/amgen ].

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])

 

 

 

 

SOURCE Amgen

[ Back to top ]

RELATED LINKS
[ http://www.amgen.com ]


Publication Contributing Sources